Dacryoscintigraphy (DSG) is a specialized nuclear medicine procedure used to evaluate the functional health of the lacrimal (tear) drainage system. Unlike traditional X-ray methods that look at the structure of the tear ducts, DSG provides a real-time assessment of how tears actually flow through the eye’s natural "plumbing" system.
Dacryoscintigraphy (Lacrimal Scintigraphy)
1. What is it? Any common name for this procedure?
Dacryoscintigraphy is a non-invasive diagnostic test that uses a small amount of radioactive tracer to map the movement of tears from the eye into the nose. It is particularly effective at diagnosing "functional" obstructions where the anatomy appears normal, but the drainage speed is insufficient.
- Common Names: Lacrimal Scintigraphy, Nuclear Dacryocystogram, Nuclear Lacrimal Scan, or DSG.
- Procedure Detail: A single drop of a radiopharmaceutical (usually Technetium-99m) is placed on the surface of the eye. A gamma camera then records the tracer’s passage over a period of 20–30 minutes.
2. Common Symptoms for Medical Consultation
This procedure is typically recommended when standard clinical tests cannot explain persistent eye issues. Consult a specialist if you experience:
- Epiphora (Excessive Tearing): Constant watering of the eye that interferes with vision or daily activities.
- Recurrent "Watery Eye": Tearing that occurs only in specific environments (like wind or cold) but feels persistent.
- Chronic Eye Irritation: A feeling of "fullness" or discomfort in the inner corner of the eye.
- Persistent Blurred Vision: Caused by a thick "tear lake" resting on the eye surface.
- Recurrent Conjunctivitis: Frequent eye infections that may be linked to stagnant tears in a blocked duct.
3. List of Associated Diseases
DSG is instrumental in identifying disorders of the lacrimal apparatus, which includes the gland and its drainage pathways:
- Nasolacrimal Duct Obstruction (NLDO): Partial or complete blockage of the main tube draining tears into the nose.
- Functional Epiphora: A condition where the drainage path is physically open (patent) but the "pump" mechanism fails to move tears efficiently.
- Dacryocystitis: Inflammation or infection of the lacrimal sac.
- Canalicular Stenosis: Narrowing of the small channels at the beginning of the drainage system.
- Ectropion: Malposition of the eyelid that prevents the tear puncta from touching the eye.
- Lacrimal Pump Failure: Weakness of the orbicularis muscle (which helps "pump" tears during blinking).
4. List of Screening Tests for This Procedure
Before undergoing a DSG, a "tear duct workup" is performed to determine if functional imaging is necessary:
- Lacrimal Syringing (Irrigation Test): A doctor flushes saline through the ducts to see if they are physically open.
- Fluorescein Dye Disappearance Test (DDT): Measuring how quickly a yellow dye clears from the eye surface.
- Jones Test: A two-stage test using dye to differentiate between an overproduction of tears and a drainage blockage.
- Slit Lamp Examination: A close-up look at the eyelid margins and the "tear meniscus" (the depth of the tear pool).
5. Am I Eligible for This Procedure?
Eligibility is focused on patients with unexplained tearing issues:
- Eligible Candidates: Individuals with chronic epiphora whose ducts appear "open" during syringing, or those being evaluated before or after tear duct surgery (DCR).
- Ineligible/High Risk: Pregnant or breastfeeding women due to the radioactive tracer.
- Acute Contraindications: Patients with active, severe eye infections or severe allergies should wait until the inflammation clears to avoid inaccurate results.
6. Pre and Post Care for This Procedure
Pre-Care:
- Face Hygiene: Arrive with a clean face; specifically, do not wear eye makeup, lotions, or creams around the eyes as they can interfere with imaging.
- Contact Lenses: You will likely be asked to remove contact lenses before the drop is administered.
- Medication: Most eye drops can be continued, but consult your doctor regarding glaucoma medications like beta-blockers, as they can sometimes affect tear turnover.
Post-Care:
- Hydration: Drink plenty of water (4–6 glasses) following the test to help flush the tracer out of your body.
- Safety Precautions: As a standard nuclear medicine precaution, avoid close contact with children (under 12) or pregnant women for 24 hours after the scan.
- Normal Activity: You can drive and return to work immediately after the test; your vision will not be blurred like it is with "dilating" drops.
7. Days Required for Hospitalization
Dacryoscintigraphy is strictly an outpatient diagnostic test.
- Procedure Duration: The actual imaging takes between 15 to 30 minutes.
- Total Clinic Time: Expect to be at the facility for 1–2 hours to account for check-in and tracer absorption.
- Hospital Stay: 0 days.
Disclaimer: As per doctor’s advise the number of day’s for monitoring may get modified based on whether the patient requires additional follow-up imaging (delayed scans) to track slow-moving tears.
8. Benefits of This Procedure
- Physiological Accuracy: DSG is the only test that measures how your eye drains tears under "normal" conditions without the pressure of forced syringing.
- Non-Invasive: There are no needles, no iodine contrast injections, and no physical probing of the delicate tear ducts.
- Functional "Map": It can pinpoint exactly where the flow slows down—whether it's at the eyelid (pre-sac), the sac itself, or the final exit into the nose (post-sac).
- Surgical Planning: It helps surgeons decide if you truly need a complex surgery like a Dacryocystorhinostomy (DCR) or if a simpler treatment will suffice.
- Minimal Radiation: The dose used is extremely low, carrying much less radiation exposure than a standard CT scan of the head.
